Por: MarketWatch Business December 23, 2023
Key clinical-trial data emerging over the next year “will really start to dictate who will be the competitors against Lilly and Novo,” said Damien Conover, director of healthcare research at Morningstar. While new, next-generation obesity drugs aren’t likely to hit the market in 2024, fascination with these medications isn’t about to fizzle out, with some analysts projecting the market could grow to $100 billion over the next five to... + full article
MarketWatch USA Business November 13, 2023
Copenhagen-listed shares of the Danish healthcare company rose 3.8% on Monday. Novo Nordisk’s American depositary receipts fell 1% premarket on Monday. The results mark the first time that any drug or lifestyle therapy has been shown to reduce cardiovascular events in adults... + más
Novo Nordisk cuts supply of certain Wegovy doses as it faces strong demand | Fox Business
Novo Nordisk weight loss drug Wegovy cuts heart disease risk by 20%, trial shows | Fox Business
CBS News USA Health November 08, 2023
The Food and Drug Administration approved a request by Eli Lilly on Wednesday to begin marketing its tirzepatide medication, which is branded as Mounjaro for diabetes, under a new brand for weight loss as well.While Mounjaro had already been used by some patients off-label for... + más
Eli Lilly Stock Jumps on Obesity Drug’s FDA Approval | MarketWatch
FDA approves new version of diabetes drug Mounjaro for weight loss | Los Angeles Times
Fox Business USA Business October 21, 2023
Long-term use of weight loss drugs poses challenges, according to doctor Drugmakers Eli Lilly and Novo Nordisk are testing some of their most and weight loss drugs on patients as young as 6. Indiana-based Lilly is planning to test tirzepatide, sold under the brand name... + más
Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly | Forbes
New Data May Push Insurers to Cover Novo, Lilly Obesity Drugs | MarketWatch
MarketWatch USA Business August 08, 2023
The positive results represent the first concrete evidence that the new class of weight-loss drugs from Novo Nordisk (ticker: NVO) and Eli Lilly (LLY) offer substantive health benefits beyond weight reduction for overweight or obese patients without diabetes. The results will... + más
The End Of Obesity | Forbes
Use medication, surgery early to treat obesity in kids, new guidance says | Portland Press Herald
Forbes USA Business March 14, 2023
Topline Pharmaceutical heavyweight Novo Nordisk on Tuesday it is cutting prices for several insulin drugs in the U.S., following a similar move from drugmaker Eli Lilly as healthcare companies come under increasing pressure to lower prices for the lifesaving diabetes medication.... + más
Novo Nordisk to lower insulin prices by 75% | Fox Business
Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly | CNBC
The Advocate USA Entertainment February 19, 2023
Le Krewe du Roi celebrated the food and fun of Louisiana with a theme of “Roi Fest: The Bounty of Louisiana” for its 58th annual Mardi Gras Ball Saturday at the Carl F. Grant Civic Center, Plaquemine.The tableau began with the presentation of the 2023 ball captains, Corey... + más
Are kids allowed at Mardi Gras parades in New Orleans? Answers to 10 common tourist questions. | The Advocate
Washington Mardi Gras exhibit is the perfect mix of Louisiana royalty and D.C. pomp | The Advocate
ABC News USA Sports October 20, 2022
AFC CLINCHED: Indianapolis-AFC South and homefield advantage; San Diego-AFC West and first-round bye; Cincinnati-AFC North; New England-AFC East ELIMINATED: Cleveland, Kansas City, Oakland, Buffalo, Tennessee Baltimore - Clinches a playoff spot with a win N.Y. Jets - Clinches a... + más
How the College Football Playoff will be impacted by Week 7's key games | ABC7
ESPN+ is streaming 9 NFL games this season — here's a full schedule and how to watch | Business Insider
About iurex | Privacy Policy | Disclaimer |